Wendye Robbins - 14 Mar 2023 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
Director
Signature
/s/ Rodney Young, Attorney-in-Fact for Wendye Robbins
Issuer symbol
RAPT
Transactions as of
14 Mar 2023
Net transactions value
+$97,612
Form type
4
Filing time
15 Mar 2023, 18:48:35 UTC
Previous filing
26 May 2022
Next filing
10 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAPT Common Stock Purchase $28,125 +1,500 +12% $18.75 13,900 14 Mar 2023 Direct F1
transaction RAPT Common Stock Purchase $7,392 +400 +2.9% $18.48 14,300 14 Mar 2023 Direct
transaction RAPT Common Stock Purchase $11,970 +600 +4.2% $19.95 14,900 14 Mar 2023 Direct
transaction RAPT Common Stock Purchase $50,125 +2,500 +62% $20.05 6,500 14 Mar 2023 By Spouse
holding RAPT Common Stock 6,100 14 Mar 2023 TRS FBO Trust of Craig and Wendye McGahey F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares has been adjusted to correct an inadvertent mathematical error in the total number of shares beneficially owned by the Reporting Person in the prior Form 4s.
F2 The Reporting Person no longer has a reportable beneficial interest in 305 shares of the Issuer's common stock owned by her daughter and included in the Reporting Person's prior ownership reports.